We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Lars Lannfelt had a key role in developing a drug that has shown some promise in tackling Alzheimer’s
Dementia drug development, diagnostics and delivery still require much more investment
Joe Biden’s coronavirus tsar says Chinese vaccines are ‘not as good’ as alternatives
Japanese company refuses to rule out possibility treatment contributed to brain bleeds
Mistakes by staff at Immensa clinic resulted in incorrect test results, finds disease protection agency
Cepi releases blueprint to move three times faster against a new virus than during Covid-19 pandemic
The early death of an Alzheimer’s patient taking part in lecanemab trials sent shares down
A sharp drop in local shares highlights the risks stemming from unpredictable politics
Employers are used to accommodating fixed disabilities, such as wheelchair users, but the challenge of variable illnesses has only recently come into focus
Results from UK-wide trials on anticoagulant Apixaban set to change protocols around the world
Bionaut Labs has raised $43.2mn in second financing round to fund first clinical trials
Social media posts allege fire services’ response was hampered by coronavirus restrictions
Addenbrooke’s seeks to tackle problems facing the health service with both low and high-tech advances
Economic and social costs are climbing but Beijing has failed to offer a way out of endless lockdowns
Rising cases in Guangzhou indicate a widening gap between official guidance and reality
There is no evidence that an individual is worse off for having avoided earlier infection
Country sticks to zero-Covid policy, with almost 28,000 new infections reported
Global supply chain disruptions could exceed those experienced in the past year
Many countries are struggling with a rise in the numbers of people reporting problems with anxiety and depression
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Medicines are often given for viral infections such as flu, for which they are useless, but can cause side effects
Eli Lilly seeks approval for weight loss medication as Novo Nordisk battles supply crunch for Wegovy
She demanded action after exposing one of the most shocking medical scandals in Ireland’s history
The avian flu outbreak is not the only thing to blame for the current egg shortage
Dr Dilip Mahalanabis changed the world. So why did we not hear more about it?
International Edition
